Author:
Cheng Qi Jian, ,Huang Shao-Guang,Chen Yu Zhi,Lin Jiang-Tao,Zhou Xin,Chen Bao-Yuan,Feng Yu-Lin,Ling Xia,Sears Malcolm R.
Publisher
Springer Science and Business Media LLC
Subject
Pulmonary and Respiratory Medicine
Reference11 articles.
1. Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention. 2015. http://www.ginasthma.org/local/uploads/files/GINA_Report_2015_Aug11 . (Accessed 5th January 2016).
2. Tattersfield AE, Lofdahl CG, Postma DS, Eivindson A, Schreurs AG, Rasidakis A, et al. Comparison of formoterol and terbutaline for as-needed treatment of asthma: a randomised trial. Lancet. 2001;357(9252):257–61. doi: 10.1016/S0140-6736(00)03611-4 .
3. Ind PW, Villasante C, Shiner RJ, Pietinalho A, Boszormenyi NG, Soliman S, et al. Safety of formoterol by Turbuhaler as reliever medication compared with terbutaline in moderate asthma. Eur Respir J. 2002;20(4):859–66.
4. Welsh EJ, Cates CJ. Formoterol versus short-acting beta-agonists as relief medication for adults and children with asthma. The Cochrane database of systematic reviews. 2010;(9):CD008418. doi:10.1002/14651858.CD008418.pub2
5. Pauwels RA, Sears MR, Campbell M, Villasante C, Huang S, Lindh A, et al. Formoterol as relief medication in asthma: a worldwide safety and effectiveness trial. Eur Respir J. 2003;22(5):787–94.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献